Crohn’s and Colitis Canada

Overview

Health Research BC and Crohn’s and Colitis Canada (CCC) partner to fund researchers whose work contributes to understanding and treating inflammatory bowel disease (IBD). Together, we've supported studies on the gut microbiome, immune system function, and gene-environment interactions to uncover the causes of Crohn’s disease and ulcerative colitis. This collaboration helps advance research that informs prevention strategies, improves treatments, and enhances quality of life for people living with IBD. CCC was founded in 1974 by a group of parents whose children were diagnosed with inflammatory bowel disease (IBD). They were concerned about the lack of funding for IBD research and they were interested in learning more about Crohn’s disease and ulcerative colitis.
From that small but dedicated group, CCC has grown to become a world leader in IBD research funding. Crohn’s and Colitis Canada is the country’s largest non-governmental funder of Crohn’s and colitis research and is the single largest patient organization in Canada focused on Crohn’s disease and ulcerative colitis, with over 40 volunteer chapters across the country. Through the support of its generous sponsors and donors, CCC funds research projects that probe the mysteries of IBD. Life-altering treatments have been developed as a result of these discoveries, and, one day, a cure will be found.